Evidence map›Paper›PMID 39254668›Full record

ArticleMicrobial genomics2024

Genetic heterogeneity in the

Aneley Getahun Strobel, Andrew J Hayes, Wytamma Wirth, Mikaele Mua, Tiko Saumalua, Orisi Cabenatabua, Vika Soqo, Varanisese Rosa, Nancy Wang, Jake A Lacey and 8 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Aneley Getahun StrobelDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Andrew J HayesDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Wytamma WirthDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Mikaele MuaLabasa Divisional Hospital, Fiji Ministry of Health, and Medical Services, Labasa, Fiji.
Tiko SaumaluaNorthern Health, Fiji Ministry of Health, and Medical Services, Labasa, Fiji.
Orisi CabenatabuaLabasa Divisional Hospital, Fiji Ministry of Health, and Medical Services, Labasa, Fiji.
Vika SoqoLabasa Divisional Hospital, Fiji Ministry of Health, and Medical Services, Labasa, Fiji.
Varanisese RosaNew Vaccines Group, Murdoch Childrens Research Institute, Melbourne, Australia.
Nancy WangDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Jake A LaceyMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Dianna HockingDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Mary ValcanisMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Adam JenneyCollege of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji.
Benjamin P HowdenMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Sebastian DucheneDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Kim MulhollandLondon School of Hygiene and Tropical Medicine, London, UK.
Richard A StrugnellDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Mark R DaviesDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Typhoid fever is endemic in many parts of the world and remains a major public health concern in tropical and sub-tropical developing nations, including Fiji. To address high rates of typhoid fever, the Northern Division of Fiji implemented a mass vaccination with typhoid conjugate vaccine (Vi-polysaccharide conjugated to tetanus toxoid) as a public health control measure in 2023. In this study we define the genomic epidemiology of

Indexed as

Polysaccharides, BacterialSalmonella typhiTyphoid FeverBacterial CapsulesFijiGenetic HeterogeneityGenotypeHumansMutationPolymorphism, Single NucleotideTyphoid-Paratyphoid Vaccinescapsular polysaccharide, SalmonellaPolysaccharides, BacterialTyphoid-Paratyphoid VaccinesepidemiologygenomicsSalmonellatviTyphiVi antigen

Identifiers

PMID39254668
PMCPMC11385387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.